我已经服用甲氨蝶呤治疗我的类风湿性关节炎(RA)好几年了，但它似乎对我的症状没有帮助。我的医生建议我在治疗方案中加入生物反应调节剂(BRM)药物，如依那西普(Enbrel)或阿达木单抗(Humira)，但我听说BRM会增加患癌症的风险。

{"title":"我已经服用甲氨蝶呤治疗我的类风湿性关节炎(RA)好几年了，但它似乎对我的症状没有帮助。我的医生建议我在治疗方案中加入生物反应调节剂(BRM)药物，如依那西普(Enbrel)或阿达木单抗(Humira)，但我听说BRM会增加患癌症的风险。","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":87434,"journal":{"name":"DukeMedicine healthnews","volume":"20 11","pages":"8"},"PeriodicalIF":0.0000,"publicationDate":"2014-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"I've been taking methotrexate for my rheumatoid arthritis (RA) for several years, but it doesn't seem to be helping my symptoms. My doctor suggested adding a biologic response modifier (BRM) drug, such as etanercept (Enbrel) or adalimumab (Humira) to my treatment plan, but I've heard that BRMs can increase cancer risk.\",\"authors\":\"\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":87434,\"journal\":{\"name\":\"DukeMedicine healthnews\",\"volume\":\"20 11\",\"pages\":\"8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"DukeMedicine healthnews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"DukeMedicine healthnews","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}